Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia

Biochemical Journal

Volumn 402, Issue 2, 2007, Pages 349-357

  Murayama, Takashi ^a   Oba, Toshiharu ^b   Hara, Hiroshi ^c   Wakebe, Kikuo ^c   Ikemoto, Noriaki ^d,e   Ogawa, Yasuo ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c National Livestock Breeding Center   (Japan)

^d BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Calcium release channel; Malignant hyperthermia; Ryanodine receptor type 1; Sarcoplasmic reticulum; Skeletal muscle

Indexed keywords

CALCIUM RELEASE CHANNELS; MALIGNANT HYPERTHERMIA; RYANODINE RECEPTOR TYPE 1; SARCOPLASMIC RETICULUM; SKELETAL MUSCLES;

HYPERTHERMIA THERAPY; LIGANDS; MUSCLE; PROTEINS; SENSITIVITY ANALYSIS;

BIOCHEMICAL ENGINEERING;

ADENINE NUCLEOTIDE; ARGININE; CALCIUM; CALCIUM CHANNEL; CYSTEINE; DP4 PEPTIDE; FK 506 BINDING PROTEIN; LEUCINE; LIGAND; MAGNESIUM; PEPTIDE; PROLINE; RYANODINE RECEPTOR 1; UNCLASSIFIED DRUG; 5' ADENYLYL (BETA,GAMMA METHYLENE)DIPHOSPHONATE; 5'-ADENYLYL (BETA,GAMMA-METHYLENE)DIPHOSPHONATE; ADENOSINE TRIPHOSPHATE; CAFFEINE; DRUG DERIVATIVE; RYANODINE; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL VACUOLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; MALIGNANT HYPERTHERMIA; MUTAGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN SYNTHESIS; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SWINE; ANIMAL; CLASSIFICATION; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN MOTIF; SECRETION;

MAMMALIA; SUIDAE; SUS;

ADENOSINE TRIPHOSPHATE; AMINO ACID MOTIFS; ANIMALS; CAFFEINE; CALCIUM; MAGNESIUM; MALIGNANT HYPERTHERMIA; PROTEIN BINDING; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SWINE; TACROLIMUS BINDING PROTEIN 1A;

EID: 33847716272     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20061040     Document Type: Article

References (51)

1. 2+ release channels and their regulation by endogenous effectors. Annu. Rev. Physiol. 56, 485-508
2. Ogawa, Y. (1994) Role of ryanodine receptors. Crit. Rev. Biochem. Mol. Biol. 29, 229-274
3. Rios, E. and Pizarro, G. (1991) Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev. 71, 849-908
4. Schneider, M. F. (1994) Control of calcium release in functioning skeletal muscle fibers. Annu. Rev. Physiol. 56, 463-484
5. Endo, M. (1977) Calcium release from the sarcoplasmic reticulum. Physiol. Rev. 57, 71-108
6. Ogawa, Y., Murayama, T. and Kurebayashi, N. (2002) Ryanodine receptor isoforms of non-mammalian skeletal muscle. Front. Biosci. 7, d1184-d1194
7. Murayama, T. and Ogawa, Y. (2002) Roles of two ryanodine receptor isoforms coexisting in skeletal muscle. Trends Cardiovasc. Med. 12, 305-311
8. McCarthy, T. V., Quane, K. A. and Lynch, P. J. (2000) Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum. Mutat. 15, 410-417
9. Jurkat-Rott, K., McCarthy, T. and Lehmann-Horn, F. (2000) Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23, 4-17
10. 2+ regulation defects. Physiol. Rev. 76, 537-592
11. Melzer, W. and Dietze, B. (2001) Malignant hyperthermia and excitation-contraction coupling. Acta Physiol. Scand. 171, 367-378
12. Yang, T., Ta, T. A., Pessah, I. N. and Allen, P. D. (2003) Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J. Biol. Chem. 278, 25722-25730
13. Ikemoto, N. and Yamamoto, T. (2002) Regulation of calcium release by interdomain interaction within ryanodine receptors. Front. Biosci. 7, d671-d683
14. 2+ channel regulation. J. Biol. Chem. 275, 11618-11625
15. 2+ release in skinned skeletal muscle fibers. Am. J. Physiol. Cell Physiol. 281, C207-C214
16. 2+ spark frequency in skeletal muscle. J. Gen. Physiol. 119, 15-32
17. 2+ channel regulation by interdomain interaction within the ryanodine receptor. Biochem. J. 380, 561-569
18. Kobayashi, S., Bannister, M. L., Gangopadhyay, J. P., Hamada, T., Parness, J. and Ikemoto, N. (2005) Dantrolene stabilizes domain interactions within the ryanodine receptor. J. Biol. Chem. 280, 6580-6587
19. Yamamoto, T. and Ikemoto, N. (2002) Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor. Biochemistry 41, 1492-1501
20. 2+ release between α- and β-RyR. J. Biol. Chem. 276, 2953-2960
21. Murayama, T. and Ogawa, Y. (2004) RyR1 exhibits lower gain of CICR activity than RyR3 in the SR: evidence for selective stabilization of RyR1 channel. Am. J. Physiol. Cell Physiol. 287, C36-C45
22. 2+ release activity of mammalian skeletal muscle sarcoplasmic reticulum. Am. J. Physiol. Cell Physiol. 288, C1222-C1230
23. Murayama, T. and Ogawa, Y. (1997) Characterization of type 3 ryanodine receptor (RyR3) of sarcoplasmic reticulum from rabbit skeletal muscles. J. Biol. Chem. 272, 24030-24037
24. Harafuji, H. and Ogawa, Y. (1980) Re-examination of the apparent binding constant of ethylene glycol bis(β-aminoethyl ether)-N,N,N′, N′-tetraacetic acid with calcium around neutral pH. J. Biochem. 87, 1305-1312
25. 2+ release through ryanodine receptors of frog skeletal muscle: modulations by adenine nucleotides and caffeine. Biophys. J. 78, 1810-1824
26. 2+ release channel response to modulators. Am. J. Physiol. Cell Physiol. 282, C684-C692
27. 2+-release channel gating and muscle contraction in a dose-dependent manner. Am. J. Physiol. Cell Physiol. 286, C1188-C1194
28. Laver, D. R., Baynes, T. M. and Dulhunty, A. F. (1997) Magnesium inhibition of ryanodine-receptor calcium channels: evidence for two independent mechanisms. J. Membr. Biol. 156, 213-229
29. 2+ and monovalent cations and anions. J. Biol. Chem. 272, 1628-1638
30. Marks, A. R. (1996) Cellular functions of immunophilins. Physiol. Rev. 76, 631-649
31. Mickelson, J. R., Gallant, E. M., Litterer, L. A., Johnson, K. M., Rempel, W. E. and Louis, C. F. (1988) Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J. Biol. Chem. 263, 9310-9315
32. 2+-release channel in malignant hyperthermia. J. Biol. Chem. 267, 6702-6709
33. 2+ release in malignant hyperthermia-susceptible pig skeletal muscle. Am. J. Physiol. 256, C358-C367
34. 2+ release from sarcoplasmic reticulum of malignant hyperthermia susceptible pigs. Biochim. Biophys. Acta 1064, 175-183
35. 2+ release channel. Am. J. Physiol. 267, C1253-C1261
36. 3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs. Arch. Biochem. Biophys. 278, 251-257
37. Fill, M., Coronado, R., Mickelson, J. R., Vilven, J., Ma, J. J., Jacobson, B. A. and Louis, C. F. (1990) Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys. J. 57, 471-475
38. 2+ release channels in malignant hyperthermia. Biophys. J. 73, 1913-1924
39. 2+ release in muscle fibers of pigs susceptible to malignant hyperthermia. Am. J. Physiol. 272, C203-C211
40. 2+ dependence of the RyR1. Biophys. J. 81, 2050-2058
41. Shomer, N. H., Louis, C. F., Fill, M., Litterer, L. A. and Mickelson, J. R. (1993) Reconstitution of abnormalities in the malignant hyperthermia- susceptible pig ryanodine receptor. Am. J. Physiol. 264, C125-C135
42. Bittar, E. E. (1964) Cell pH, Butterworth Inc., Washington, DC
43. Hagberg, H., Larsson, S. and Haljamae, H. (1983) A new design of double-barrelled microelectrodes for intracellular pH-measurement in vivo. Acta Physiol. Scand. 118, 149-153
44. Endo, M., Yagi, S., Ishizuka, T., Horiuti, K., Koga, Y. and Amaha, K. (1983) Changes in the Ca-induced Ca release mechanism in the sarcoplasmic reticulum of the muscle from a patient with malignant hyperthermia. Biomed. Res. 4, 83-92
45. Kawana, Y., Iino, M., Horiuti, K., Matsumura, N., Ohta, T., Matsui, K. and Endo, M. (1992) Acceleration in calcium-induced calcium release in the biopsied muscle fibers from patients with malignant hyperthermia. Biomed. Res. 13, 287-297
46. Richter, M., Schleithoff, L., Deufel, T., Lehmann-Horn, F. and Herrmann-Frank, A. (1997) Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J. Biol: Chem. 272, 5256-5260
47. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease. J. Biol. Chem. 272, 26332-26339
48. 2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys. J. 87, 3193-3204
49. Yamamoto, T. and Ikemoto, N. (2002) Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor. Biochem. Biophys. Res. Commun. 291, 1102-1108
50. 2477 (DP4) region of RyR1 are clustered in a structurally and functionally definable area. Biochem. J. 401, 333-339
51. 2+ release channels? Trends Cardiovasc. Med. 12, 189-197